Pope H G, Keck P E, McElroy S L
Am J Psychiatry. 1986 Oct;143(10):1227-33. doi: 10.1176/ajp.143.10.1227.
Neuroleptic malignant syndrome, a dangerous but little-known complication of antipsychotic drugs, is often assumed to be rare. To assess the frequency of the syndrome in a large psychiatric hospital, the authors first reviewed the literature and developed operational diagnostic criteria. Using these criteria to survey nearly 500 neuroleptic-treated patients admitted during a 1-year period, they found that seven (1.4%) had experienced definite or probable neuroleptic malignant syndrome. In several cases, including one fatal case, the diagnosis of neuroleptic malignant syndrome was not immediately considered. The authors conclude that neuroleptic malignant syndrome may be more common than previously thought and may be underdiagnosed.
抗精神病药物恶性综合征是抗精神病药物一种危险但鲜为人知的并发症,人们常常认为它很罕见。为了评估一家大型精神病医院中该综合征的发生率,作者首先查阅了文献并制定了操作性诊断标准。他们使用这些标准对在1年期间收治的近500例接受抗精神病药物治疗的患者进行调查,发现有7例(1.4%)经历了明确或可能的抗精神病药物恶性综合征。在几例病例中,包括1例死亡病例,抗精神病药物恶性综合征的诊断并未被立即考虑。作者得出结论,抗精神病药物恶性综合征可能比之前认为的更为常见,且可能存在诊断不足的情况。